. 2015 Jan 7;4(1):9–17. doi: 10.1530/EC-14-0119
This work is licensed under a Table 3.
Description of skeletal-related events (SREs) among all patients diagnosed with bone metastases.
| Carcinoid (n=30) | PNET (n=12) | High-grade NEC (n=9) | Pheo/para (n=25) | Other/unknown (n=6) | Total (n=82) | P valuea | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | ||
| Bone pain | 18 | 60 | 9 | 75 | 4 | 44 | 15 | 60 | 5 | 83 | 51 | 62 | 0.566 |
| Cord compression | 1 | 3 | 1 | 8 | 0 | 0 | 5 | 20 | 1 | 17 | 8 | 10 | 0.130 |
| Pathological fracture | 1 | 3 | 1 | 8 | 0 | 0 | 2 | 8 | 3 | 50 | 7 | 9 | 0.723 |
| Hypercalcemia | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 12 | 0 | 0 | 3 | 4 | 0.095 |
| Surgery or radiation | 15 | 50 | 7 | 58 | 1 | 11 | 11 | 44 | 3 | 50 | 37 | 45 | 0.148 |
| >1 SRE | 1 | 3 | 2 | 17 | 0 | 0 | 5 | 20 | 3 | 50 | 11 | 13 | 0.135 |
PNET, pancreatic neuroendocrine tumor; pheo/para, pheochromocytoma or paraganglioma; high-grade NEC, high-grade neuroendocrine carcinoma.
a
P values were calculated using the χ2 test for each SRE type according to the tumor.